Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “psoriasis”
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00287118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT03924427. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Blue Light for Treating Psoriasis Vulgaris
ClinicalTrials.gov study NCT02004847. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03573323. IPD Sharing: YES. Countries: 3. Publications: 4.
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01710046. IPD Sharing: Not stated. Countries: 1. Publications: 2.
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
ClinicalTrials.gov study NCT02132936. IPD Sharing: NO. Countries: 1. Publications: 4.
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis
ClinicalTrials.gov study NCT02195349. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
ClinicalTrials.gov study NCT03343639. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
ClinicalTrials.gov study NCT00245765. IPD Sharing: Not stated. Countries: 2. Publications: 1.
AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00941031. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT02207231. IPD Sharing: Not stated. Countries: 10. Publications: 10.
A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
ClinicalTrials.gov study NCT01347255. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03410992. IPD Sharing: NO. Countries: 9. Publications: 7.
Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
ClinicalTrials.gov study NCT04211389. IPD Sharing: NO. Countries: 2. Publications: 3.
Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02905006. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03370133. IPD Sharing: NO. Countries: 11. Publications: 10.
Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT01708590. IPD Sharing: YES. Countries: 6. Publications: 1.
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT02931838. IPD Sharing: Not stated. Countries: 8. Publications: 4.
A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
ClinicalTrials.gov study NCT02326272. IPD Sharing: Not stated. Countries: 4. Publications: 4.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03598790. IPD Sharing: YES. Countries: 13. Publications: 10.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.